GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
115 hedge funds and large institutions have $74M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
115
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.84M | |
| 2 | +$1.02M | |
| 3 | +$678K | |
| 4 |
LCM
Lonestar Capital Management
San Francisco,
California
|
+$354K |
| 5 |
JPMorgan Chase & Co
New York
|
+$33K |
Top Sellers
| 1 | -$6.22M | |
| 2 | -$5.73M | |
| 3 | -$631K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$260K |
| 5 |
Millennium Management
New York
|
-$158K |